Zentalis Pharmaceuticals, Inc.
$338.94M- Market cap
- $290.27M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 5.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · price snapshotP/S 4.31x
$4.05Snapshot Sep 8, 2026, 3:38 PM ET
Implied fair value · at MLM's multiple
$4.7316.8% above market
0.94 ZNTL revenue / share×5.03x MLM P/S=$4.73
Market $4.05Implied $4.73
MLM · price snapshotP/S 5.03x
$514.67Snapshot Sep 8, 2026, 3:38 PM ET
Implied fair value · at ZNTL's multiple
$440.7914.4% below market
102.39 MLM revenue / share×4.31x ZNTL P/S=$440.79
Market $514.67Implied $440.79